Knowledge of safety and herb-drug interactions amongst HIV+ individuals: A focus group study

Canadian Journal of Clinical Pharmacology

Volumn 11, Issue 2, 2004, Pages

  Leonard, Blair ^a   Huff, Hal ^b   Merryweather, Bill ^c   Lim, Aileen ^c   Mills, Edward ^b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b CANADIAN COLLEGE OF NATUROPATHIC MEDICINE   (Canada)

^c Sherbourne Health Centre   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

Complementary medicine; Herb drug interactions; HIV

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HERBACEOUS AGENT; NATURAL PRODUCT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALTERNATIVE MEDICINE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG USE; HEALTH CARE; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HERB DRUG INTERACTION; HERBAL MEDICINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNET; MALE; MEDICAL INFORMATION; ATTITUDE TO HEALTH; INFORMATION DISSEMINATION; INFORMATION PROCESSING; METHODOLOGY; PATIENT EDUCATION; PHYTOTHERAPY; PSYCHOLOGICAL ASPECT;

ANTI-HIV AGENTS; COMPLEMENTARY THERAPIES; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HERB-DRUG INTERACTIONS; HIV INFECTIONS; HUMANS; INFORMATION DISSEMINATION; MALE; PATIENT EDUCATION; PHYTOTHERAPY;

EID: 33645499529     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Fairfield KM, Eisenberg DM, Davis RB, Libman H, Phillips RS. Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Arch Intern Med 1998; 158:2257-64.
2. Furler MD, Einarson TR, Walmsley S, Millson M, Bendayan R. Use of complementary and alternative medicine by HIV-infected outpatients in Ontario, Canada. AIDS Patient Care STDS 2003; 17:155-68.
3. Wynia MK, Eisenberg DM, Wilson IB. Physician-patient communication about complementary and alternative medical therapies: a survey of physicians caring for patients with human immunodeficiency virus infection. J Altern Complement Med 1999; 5:447-56.
4. Foote-Ardah CE. The meaning of complementary and alternative medicine practices among people with HIV in the United States: strategies for managing everyday life. Sociol Health Illn 2003; 25:481-500.
5. London AS, Foote-Ardah CE, Fleishman JA, Shapiro MF. Use of alternative therapists among people in care for HIV in the United States. Am J Public Health 2003; 93:980-7.
6. Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Falloon J. Indinavir concentrations and St John's wort. Lancet 2000; 355:547-8.
7. Piscitelli SC, Burstein AH, Welden N, Gallicano KD, Falloon J. The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin Infect Dis 2002; 34:234-8.
8. Slain D, Amsden JR, Khakoo RA. Effect of high-dose Vitamin C on the steady state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers. 43rd ICAAC, Sept; 2003:Abstract A 1610.
9. de Maat MM, Hoetelmans RM, Math t RA, et al. Drug interaction between St John's wort and nevirapine. Aids 2001; 15:420-1.
10. Huber JT, Gullion JS. Complementary and alternative medicine as represented in the HIV/AIDS body of knowledge: a bibliometric analysis. Med Ref Serv Q 2003; 22:23-32.
11. Kitzinger J. Introducing focus groups. BMJ 1995; 311:299-302.
12. Morgan DL, Kreuger RA. Successful Focus Groups: Advancing the state of the Art. Sage 1993; CA, USA.
13. Kreuger RA. Focus Groups: A practical guide for applied research, 2nd edn. Sage 1997; London, UK.
14. Mills E, Singh R, Kawasaki M, et al. Examination of Health Food Store Practices: Advice Presented to the HIV Community. Can J Pub Health 2003; 5:363-366.
15. Ernst E. Harmless herbs? A review of the recent literature. Am J Med 1998; 104:170-8.
16. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 2001; 61:2163-75.
17. Sandhu RS, Prescilla RP, Simonelli TM, Edwards DJ. Influence of goldenseal root on the pharmacokinetics of indinavir. J Clin Pharmacol 2003; 43:1283-8.
18. Piscitelli SC, Formentini E, Burstein AH, Alfaro R, Jagannatha S, Falloon J. Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers. Pharmacotherapy 2002; 22:551-6.
19. Gallicano K, Foster B, Choudhri S. Effect of short-term administration of garlic supplements on single-dose ritonavir pharmacokinetics in healthy volunteers. Br J Clin Pharmacol 2003; 55:199-202.
20. Mills EJ, Wilson K, Foster BC, et al. Determining if ingestion of Silybum Marianum (Milk Thistle) influences the metabolism of indinavir in healthy subjects: a randomized controlled phase I study. Unpublished 2004.
21. DiCenzo R, Shelton M, Jordan K, et al. Coadministration of milk thistle and indinavir in healthy subjects. Pharmacotherapy 2003; 23:866-70.